Posts

Showing posts with the label Progressive Multifocal Leukoencephalopathy Treatment

Innovative Report on Progressive Multifocal Leukoencephalopathy Treatment Market with Competitive Analysis, New Business Developments and Top Companies, Forecast to 2024

Image
Global Progressive Multifocal Leukoencephalopathy Treatment Market Industry Analysis: Progressive multifocal leukoencephalopathy (PML) is a rare viral disease characterized by progressive damage to the white matter of the brain at different locations. Progressive multifocal leukoencephalopathy destroys the brain cells that produce the protective coating (myelin) of the CNS. PML is active in about 26% of the people living with AIDS, generally in patients whose CD4 count is well below 100. Besides, the number of patients being recognized in the context of immunosuppressive therapies for autoimmune diseases is increasing. Furthermore, the prevalence of chronic but asymptomatic JCV infection in the general population is high. PML also occurs in patients suffering from hematological malignancies, multiple sclerosis and in patients with organ transplant. The Progressive Multifocal Leukoencephalopathy Treatment market research report helps grab the attention of the clients through the f...